Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective. (2022). Biomolecules and Biomedicine, 22(5), 699-706. https://doi.org/10.17305/bjbms.2021.7326